logo
Plus   Neg
Share
Email

Thermo Fisher Reportedly Considers To Buy Diagnostics Firm Qiagen

Thermo Fisher Scientific Inc. (TMO), the maker of diagnostic equipment, is considering a purchase of molecular testing firm Qiagen NV (QGEN,QGENF), Bloomberg reported citing people familiar with the matter.

The Dutch company Qiagen, which is listed in New York and Frankfurt, has a market value of about $8 billion as of Wednesday's close.

There's no certainty the discussion will lead to a deal, and other bidders for Qiagen could emerge, the report said.

QGEN closed Wednesday regular trading at $35.45, up $3.19 or 9.89 percent. In the after-hours, the stock further gained $0.70 or 1.97 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
NBCUniversal unveiled Peacock, a free premium ad-supported streaming service with subscription tiers offering more than 600 movies and 400 series. Peacock will be available on April 15 for Comcast's Xfinity X1 and Flex customers and on July 15 for the rest of the country. NBC is offering Peacock... The number of Amazon Prime members in the U.S. is growing slowly, but steadily, a recent study has shown. According to the survey by the Consumer Intelligence Research Partners, LLC or CIRP, the number of Amazon Prime members in the U.S. is estimated to have risen to 112 million in December 2019 from just over 100 million in the same period of the prior year. Medical device manufacturer Cardinal Health will soon recall certain Level 3 surgical gowns or PreSource procedural packs that contain these gowns following warning that they may not be sterile, the U.S. Food and Drug Administration said in a statement. The health regulator said it is working with the company to find out the specific product lots that are impacted.
Follow RTT
>